Bing Yu
Nanning, 530007, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Comparative efficacy of preventive vs. therapeutic resveratrol in modulating gut microbiota and alleviating inflammation in DSS-induced colitis.
Journal: BMC immunology
Published: February 21, 2026
Resveratrol alleviates IBD-associated neuropsychiatric comorbidities via microbiota-dependent arginine metabolism reprogramming and microglial M2 polarization through gut-brain axis.
Journal: Cell communication and signaling : CCS
Published: May 21, 2025
Comparative efficacy of preventive vs. therapeutic resveratrol in modulating gut microbiota and alleviating inflammation in DSS-induced colitis.
Journal: BMC immunology
Published: March 21, 2025
Resveratrol Alleviates Liver Fibrosis by Targeting Cross-Talk Between TLR2/MyD88/ERK and NF-κB/NLRP3 Inflammasome Pathways in Macrophages.
Journal: Journal of biochemical and molecular toxicology
Published: December 04, 2024
Systematically analysis of decompensated cirrhotic patients with spontaneous bacterial peritonitis to identify diagnostic and prognostic indexes.
Journal: BMC infectious diseases
Published: May 24, 2023
Cavernous hemangioma of the ileum in a young man: A case report and review of literature.
Journal: World journal of clinical cases
Published: February 19, 2022
Diagnostic and Predictive Value of Immune-Related Genes in Crohn's Disease.
Journal: Frontiers in immunology
Published: December 29, 2020
Resveratrol improves CCL4-induced liver fibrosis in mouse by upregulating endogenous IL-10 to reprogramme macrophages phenotype from M(LPS) to M(IL-4).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026